Introduction
The recognition of the bacteria family Bartonellaceae , genus Bartonella has expanded during the past decade from the single Bartonella bacilliformis to 17 currently identified species (Table 1) . At least six of these ( B. bacilliformis, B. henselae, B. quintana, B. elizabethae , B. clarridgeiae and B. vinsonni arupensis ) are responsible for human diseases. 1, 2 The growing knowledge in this field of pathology and the new insights provided by molecular biology suggest that the number of recognized Bartonella spp . and human diseases caused by them will continue to increase in the coming years.
This review focuses on the cutaneous manifestations of bartonelloses, emphasizing selected controversial topics about angiomatous skin lesions.
Cat scratch disease
Cat scratch disease (CSD) is the most common Bartonella infection worldwide. 1 In patients with history of cat contact or scratches, the disease typically presents as a lymphadenopathy preceded by an erythematous papule at the inoculation site ( Fig. 1 ). This cutaneous lesion develops 3 -10 days after inoculation 3 and usually evolves through erythematous, vesicular, and papular crusted stages, persisting for about 1 -3 weeks. 4 Hence, it may still be present as a crusted erythematous papule 2 -6 mm in diameter when the regional lymphadenopathy develops 3 -50 days after inoculation. The histopathology of the skin lesion is similar to the lymph node changes consisting of a diffuse inflammatory cell infiltrate associating numerous neutrophils and histiocytes admixed with scattered eosinophils and plasma cells. Epidermal hyperplasia and dermal deposits of proteoglycans may also be present in the skin. 5 Warthin-Starry silver stain frequently reveals clustered bacteria within micro-abscesses, with progressive clearing of these micro-organisms as the lesion resolves. 5 Other, more unusual, skin manifestations include morbilliform eruptions, urticaria, erythema nodosum, erythema multiforme and erythema marginatum.
It is widely accepted that B. henselae is the primary etiologic agent of CSD. 6 Although it is currently impossible to reproduce CSD in a host other than the cat to fulfill the Koch's postulates, 'evidence of causation' for B. henselae was demonstrated in CSD using molecular biology. 7 However, two recent case reports identified B. clarridgeiae as the suspicious causative agent. 8, 9 There have also been cases without evidence of Bartonella infection despite appropriate search. For example, when immunofluorescence assay was applied to serum from patients with the most strictly defined CSD cases, 5 -15% of these samples yielded negative results. 10 Finally, the role of Afipia felis , initially considered to be the cause of CSD, is not ruled out, it being possible that this and other bacteria may be involved in a small percentage of CSD cases. 6 
Trench fever
In the past, trench fever was one of the most widespread bartonelloses. Transmitted by the body louse, the disease became rare after World War II, but surged again during the last decade in poor, homeless, alcoholic men living in urban areas. 11 This disease, caused by B. quintana , follows a cyclic clinical evolution combining fever, malaise, chills, anorexia, sweating, headache, conjunctival injection, myalgias and arthralgias. About 80 -90% of the patients present crops of erythematous macules or papules measuring 1 cm or less on the abdomen, chest and back. 2 These cutaneous manifestations have not been thoroughly studied using histopathology. As the condition is quite fleeting, it would be expected to demonstrate only minimal, if any vasculitis.
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Bacillary angiomatosis
The first case of bacillary angiomatosis (BA) was reported in an AIDS patient. 12 . Nearly 10 years later, B. henselae and B. quintana were demonstrated from cutaneous lesions and blood of affected individuals by direct cultivation and polymerase chain reaction (PCR)-amplification of specific gene sequences. 13 AIDS-associated BA was most frequently seen when the CD4 count decreased to less than 100 cells / mm. 12, 14 It was also described in immunocompromised cardiac and renal transplant patients 15 and in patients under chemotherapy for hematologic malignancies 16 as well as in apparently immunocompetent individuals. 17, 18 Bacillary angiomatosis was identified in different tissues including skin, brain, bone, lymph nodes, gastrointestinal and respiratory tract and bone marrow. 4, 15 Epidemiological studies have shown skin lesions to be the most frequent clinical manifestation of the disease, ranging from 55% to 90% of cases. 14, 19 It is noteworthy that the incidence of BA has been dramatically reduced since the introduction of AIDS tritherapy and prophylactic antibiotherapy. The typical lesion is solitary or dispersed all over the body. The reddish-purple papule about 1 cm in diameter ( Fig. 2 ) and may be difficult to differentiate clinically from Kaposi's disease, epithelioid hemangioma and pyogenic granuloma, 6 making it mandatory to examine a skin biopsy to confirm the diagnosis. Other BA lesions present under different aspects including smooth, warty and pedunculated papules, as well as subcutaneous nodules and hyperkeratotic plaques. They are rarely ulcerated or bleeding.
Etiology
There is a current trend to curb the BA incidence, probably due to the extensive use of antimicrobial drugs as prophylactic agents in immunocompromised patients. 5 In the USA, BA is produced almost in equal proportion by B. henselae and B. quintana. 13, 20 In contrast, B. henselae has only recently been identified in Europe as an agent causing the disease. 21 There is a lack of information about the causative organism(s) in the other continents. From the few reports available where serious efforts were made to identify the bacteria, there is at least one unsuccessful attempt; interestingly in two immunocompetent individuals with lesions histologically mimicking BA but lacking clumps of bacilli. 22 These findings leave an open door for searching for other Bartonella spp . or bacteria in BA lesions. The microbiological characterization of BA should be made, when possible, for understanding the BA etiology.
Pathophysiology
It is clear that BA is a consequence of assaults by body louse ( B. quintana ), cat scratch and cat fleas ( B. henselae ), 2 and there is evidence for Bartonella spp . ability to produce angiogenic factors. 23, 24 Both micro-organisms have a similar ability to produce cutaneous lesions but, while the latter is more prone to produce liver peliosis and lymph node disease, B. quintana is associated with a greater propensity to produce bony and subcutaneous lesions. 20 Liver peliosis is somewhat microscopically different from BA. This difference may reflect particular characteristics of this organ such as the proportion of epithelial to mesenchymal components and the vascular pattern. 25 It is unclear why B. henselae produces CSD in some cases and BA in others, and why B. quintana produces diseases as distinct as trench fever, endocarditis and BA. It is obvious that an as yet unidentified immunological parameter of the host influences the different clinical manifestations of these bartonelloses. While the immune status clearly affects the clinical presentation, differences in virulence among various Bartonella strains may also be responsible for the varied disease presentations. 6 
Histopathology
The BA histological criteria are well defined. 22, 26, 27 The main salient features are a lobular accumulation of rounded blood vessels with plump endothelial cells. Cell necrosis, atypia and mitoses are especially found in densely cellular areas. A mixed inflammatory cell infiltrate with predominance of neutrophils and occasional leukocytoclasia is also present. Granular eosinophilic and Warthin-Starry-positive bacilli are the hallmark of the lesion. In addition, numerous Factor XIIIa's-positive dermal dendrocytes are present in BA. 28 There is indeed increasing evidence regarding the immunological activity of dermal dendritic cells and their interaction with the skin endothelium. 29 The large spectrum of angiogenesis-related factors 30 might also offer new research avenues in BA.
Verruga peruana
Detailed reviews have been presented about the etiology, pathogenesis, clinical presentation and treatment of verruga peruana. 31 -34 Bartonella bacilliformis , the etiologic agent of the disease was the first identified member of the Bartonella genus. The disease is typically confined to Andean valleys of Peru, Colombia and the Equator, due to the ecologic distribution of its vector, the sand fly Lutzomia verrucarum. 31 Verruga peruana is an eruptive angiomatous disease of the skin (Figs 3 and 4 ) that typically develops 2 months after an acute phase of bacteriemic disease known as Oroya fever or Carrion's disease. In addition to the casual presentation of the angiomatous lesions, 28, 34, 35 malignant-looking aspects have been identified. 36 There is a great histological similarity between the disease BA in HIV-positive individuals. 37 However, verruga peruana differs from BA at the microscopical level, at least by the lack of aggregates of bacilli (Table 2) .
Actually, verruga peruana does not seem to be confined to the recognized epidemiological villages where it was originally documented anymore. We have indeed seen some cases of angiomatous lesions resembling verruga peruana in apparently immunocompetent individuals without any recognized risk factor including travel to verrucogenous areas and Oroya fever. As Bartonella spp . other than B. bacilliformis have been isolated from rodents in villages of Peru, 38 some of these angiomatous lesions with incomplete or absent epidemiological support could represent diseases caused by Bartonella spp . different from B. bacilliformis . On the other hand, there are no documented cases regarding the occurrence of diseases caused by B. bacilliformis in HIV-infected individuals. Finally, the immunodeficiency status associated with the majority of cases of BA, mainly CD4+ lymphocyte depletion and phagocytic dysfunction, could be compared with the immunological changes produced in the Oroya fever. 39 This could provide a suitable model of the influence of the immunological status on the development of some vascular lesions of the skin. 
Skin and the immune system in bartonelloses
The skin-restricted features of verruga peruana and the predominant skin manifestations in BA together with the immunological impaired status found in both diseases make it attractive to suggest a common pathobiological pathway. The skin might be a target of specific infectious agents responsible for angiomatous diseases in the setting of impaired immune function. Indeed, angiogenesis is a biological event strictly controlled and associated with wound healing, several chronic inflammatory diseases and tumor growth and metastasis. 40 -43 The statement that Bartonella -associated vascular lesions may represent some variants of these angiogenic responses has already been made 44 and calls for further research. The ability of Bartonella spp . to produce angiogenic factors 24, 44 might also be considered when analyzing the complex interaction between bacteria, skin cells and the immune system.
The immune function of the skin was emphasized many years ago under the concept of 'skin-associated lymphoid tissue' constituted by keratinocytes, Langerhans cells, T-cells and endothelial cells. 45 The biological interactions between cutaneous dendritic cells, endothelial cells and skin lymphocytes is altered in some pathological conditions. For instance, there is cumulated data related to the biology of the skin in HIV-disease [46] [47] [48] [49] and the vascular proliferation in BA may represent a defect in the phagocytic function and development of granulomatous reactions such as those found in CSD. 50 In addition, B. bacilliformis tropism for the skin could be caused by the better growth of the bacilli at lower temperatures with dermal dendrocytes also playing a role.
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Conclusion
Bartonella spp . infections are responsible for different clinical presentations including vascular growths in the skin. Further research must be guided in order to identify the whole spectrum of the pathogens, in particular Bartonella spp . responsible for vascular lesions. The cellular and molecular components of BA and verruga peruana lesions should be scrutinized. Some analogy among these diseases could provide evidence for common biological mechanisms. 
